Industry Investment Rating - The industry investment rating is "Outperform" [1] Core Viewpoints - The report is optimistic about the second half of 2025, particularly regarding ADC, bispecific antibodies, and CAR-T products, with expectations for continued business development (BD) activity [4][13] - In the first half of 2025, China's innovative drug license-out total amount approached $66 billion, surpassing the total for 2024, indicating strong interest from multinational corporations (MNCs) in Chinese innovative drug assets [4][13] - The report highlights a significant increase in the number and amount of license-out transactions in China, with the proportion of projects rising from 3% in 2019 to 13% in 2024, and the amount from 1% to 28% [4][13] Summary by Sections 1. Weekly Insights - The pharmaceutical and biotechnology sector rose by 1.82%, outperforming the CSI 300 index by 1 percentage point, ranking 16th among 31 sub-industries [5][20] - The report notes that the medical research outsourcing sector had the highest increase, up by 9.29% [5][24] 2. Performance of Sub-sectors - The report details the performance of various sub-sectors, with the medical research outsourcing sector leading the gains, followed by vaccines and pharmaceutical distribution [5][24] - The report indicates that the innovative drug sector continues to perform well, driven by ongoing BD activities and supportive policy developments [26][27] 3. Recommended and Benefiting Stocks - Recommended stocks include innovative drug companies such as Xinda Biopharmaceutical, Kangfang Biopharmaceutical, and others in the medical device sector like Yingke Medical and Maipu Medical [6][20] - Benefiting stocks also include a range of innovative drug companies listed in both H-shares and A-shares, as well as companies in the medical device and CXO sectors [6][20] 4. Market Trends - The report emphasizes the increasing focus of MNCs on metabolic endocrine and autoimmune products, indicating a shift in disease spectrum preferences [4][19] - The report suggests that the innovative drug sector is likely to see continued strong performance due to favorable policies and market conditions [26][28] 5. Future Outlook - The report anticipates that the innovative drug sector will continue to thrive, with a focus on projects that have already been licensed out and are awaiting clinical catalysts [26][28] - The medical device sector is expected to benefit from government policies promoting upgrades and replacements, with a significant increase in procurement anticipated in the second quarter of 2025 [29][30]

Industry Investment Rating - The industry investment rating is maintained at "Outperform the Market" [1] Core Viewpoints - The current industry fundamentals have not changed significantly, but there is an increasing expectation for policy stimulus. Future policies are expected to focus on existing building renovations, old community upgrades, complete community construction, and smart city development, rather than large-scale demolitions and constructions. China Jinmao is highlighted as a key company to watch due to its strong shareholder background and increased land acquisition intensity this year. As of the first half of 2025, Jinmao reported a cumulative contracted sales amount of 53.347 billion yuan, a year-on-year increase of 19.77%, indicating potential for continued improvement in operational performance [4][5]. Summary by Relevant Sections 1. Industry Fundamentals Tracking - New home transaction area in 30 major cities last week was 1.2667 million square meters, with a cumulative area of 49.2489 million square meters for the year, reflecting a year-on-year decrease of 2.8%. The average transaction area over the past four weeks was 2.1148 million square meters, down 14.7% year-on-year and 5.6% month-on-month. In first-tier cities, the average transaction area was 58080 square meters, down 18.3% year-on-year and 7% month-on-month [5][13]. - The inventory of available residential properties in 14 cities was 79.8571 million square meters, down 9.75% year-on-year, with a month-on-month increase of 0.64%. The average de-stocking period for these cities is 17.13 months, with first-tier cities at 12.07 months [15][21]. 2. Market Performance Review - Last week, the A-share Shenwan一级房地产行业 index rose by 6.12%, outperforming the CSI 300 index, which increased by 0.82%, by 5.3 percentage points. In the Hong Kong market, the Hang Seng Property Services and Management Index fell by 1.04%, while the Hang Seng Composite Index decreased by 1.09% [28][29]. 3. Key Company Performance - Key A-share real estate stocks that saw significant gains last week included Greenland Holdings (+26.83%), Quzhou Development (+23.67%), and Fuxing Shares (+13.89%). In the Hong Kong market, leading real estate stocks included Greentown China Holdings (+21.62%), Shenzhen Holdings (+15.73%), and Agile Group (+12.94%) [32].

Investment Rating - The investment rating for the company is "Buy" [12] Core Views - The company is expected to achieve a net profit of 16.5 billion to 17 billion yuan for the first half of 2025, representing a year-on-year increase of 71.65% to 76.85% [5] - The second quarter net profit is projected to be 9.45 billion yuan, showing a year-on-year growth of 54.7% [6] - The company benefits from a high proportion of mid-to-high-end products, particularly in the wind power and thermoplastic sectors, which are expected to maintain high demand [6] - Anticipated growth in AI demand is expected to drive the need for Low-DK/Low CTE electronic fabrics [6] Financial Performance - The company forecasts revenues of 193 billion yuan and 209 billion yuan for 2025 and 2026, respectively, with year-on-year growth rates of 21.5% and 8.5% [7] - The projected net profit for 2025 and 2026 is 34.5 billion yuan and 37.2 billion yuan, respectively, with growth rates of 41.2% and 7.7% [7] - The company's PE ratios for 2025 and 2026 are expected to be 14X and 13X, respectively [7] Financial Metrics - The latest closing price is 12.17 yuan, with a total market capitalization of 487 billion yuan [4] - The company has a debt-to-asset ratio of 41.1% and a PE ratio of 19.93 [4] - The projected EBITDA for 2025 is 44.72 billion yuan, with a net profit margin of 17.9% [10][11]

证券研究报告：基础化工|行业周报 发布时间：2025-07-14 行业投资评级 强于大市|维持 | 行业基本情况 | | --- | | 收盘点位 | | 3572.47 | | --- | --- | --- | | 52 | 周最高 | 3587.1 | | 52 | 周最低 | 2687.54 | 行业相对指数表现 -11% -8% -5% -2% 1% 4% 7% 10% 13% 16% 19% 22% 2024-07 2024-09 2024-12 2025-02 2025-04 2025-07 基础化工 沪深300 资料来源：聚源，中邮证券研究所 研究所 分析师:张泽亮 SAC 登记编号:S1340523100003 Email:zhangzeliang@cnpsec.com 分析师:许灿杰 SAC 登记编号:S1340525040002 Email:xucanjie@cnpsec.com 近期研究报告 《关注"反内卷"下供改相关机会》 - 2025.07.07 基础化工行业报告 （2025.07.07-2025.07.11） 持续关注"反内卷"和业绩线机会 ⚫ 投资要点 7 月 1 日习总书记主 ...

证券研究报告：固定收益报告 发布时间：2025-07-14 研究所 分析师:梁伟超 SAC 登记编号:S1340523070001 Email:liangweichao@cnpsec.com 分析师:李书开 SAC 登记编号:S1340524040001 Email:lishukai@cnpsec.com 近期研究报告 ⚫ 调整后信用如何布局？ 七月第二周，债市进入盘整阶段，信用债跌幅小于利率。上周利 空因素较多且占据主导，"股债跷跷板"效应持续发力，权益走强而利 率走弱，此外农商行监管趋严，棚改重启预期升温等因素也一度左右 行情，市场止盈氛围较浓厚；全周来看利率债收益率震荡上行，有所 调整。信用债走势跟随利率，同样有所调整，但幅度相对利率债而言 更小，显示出一定的抗跌属性。 超长期限信用债同样有所调整，调整幅度不及普信债但多数超过 同期限利率债，其中城投超长债调整幅度最高，仅有 AA+10Y 中票表 现较好，估值收益率继续下行。AAA/AA+10Y 的中票收益率分别上行 了 2.62 BP、下行了 1.38BP。此外 AAA/AA+10Y 的城投收益率分别上 行了 3.36BP、4.36 BP，而 10Y ...

Investment Rating - The report assigns a "Buy" rating for the company, marking its first coverage [1][9]. Core Insights - The demand for audio and acoustic products is rapidly increasing, with product iterations and usage scenarios expanding beyond traditional home and entertainment settings into education, hospitality, healthcare, sports, and finance, which is expected to drive market demand and consumption upgrades [4]. - The integration of AI with hardware is leading to a surge in innovative smart hardware products, such as smart speakers and AI glasses, with the company leveraging its expertise in audio technology to secure new projects and orders from major clients [5]. - The automotive audio system is undergoing significant upgrades, with the number of speakers per vehicle doubling from 4-8 to 20-30, enhancing the value of in-car audio systems [6]. - The global market for small soft-pack lithium-ion batteries is experiencing a resurgence, with an expected shipment of 5.96 billion units in 2024, driven by innovations in consumer electronics [7]. Financial Projections - The company is projected to achieve revenues of 102.4 billion, 130.7 billion, and 165.2 billion yuan for the years 2025, 2026, and 2027 respectively, with net profits of 2.4 billion, 3.3 billion, and 4.5 billion yuan for the same years [9][11]. - The revenue growth rates are forecasted at 33.17% for 2024, 29.63% for 2025, 27.60% for 2026, and 26.43% for 2027 [11]. - The company's earnings per share (EPS) are expected to be 0.45 yuan in 2024, increasing to 0.81 yuan by 2027 [11]. Company Overview - The latest closing price of the company's stock is 15.54 yuan, with a total market capitalization of 8.7 billion yuan [3]. - The company has a debt-to-asset ratio of 54.9% and a price-to-earnings (P/E) ratio of 33.78 [3]. - The largest shareholder is Shenzhen Zhidu Guoguang Investment Development Co., Ltd. [3].

Investment Rating - The report maintains a "Buy" rating for the company, expecting a relative increase in stock price of over 20% compared to the benchmark index within the next six months [9][15]. Core Views - The company is projected to achieve significant revenue growth driven by the expansion of membership channels and new product launches, with a forecasted revenue of 7.46-7.98 billion yuan for the first half of 2025, representing a year-on-year increase of 40.91%-50.77% [4][5]. - The company is focusing on optimizing channel structures and innovating products, with membership supermarkets and snack wholesale channels becoming key growth drivers [5][6]. - The report highlights a positive outlook for the company's profitability, with net profit for the first half of 2025 expected to be between 1.05-1.12 billion yuan, a year-on-year increase of 37.91%-47.57% [4][6]. Summary by Sections Company Overview - The latest closing price is 12.43 yuan, with a total market capitalization of 5.3 billion yuan [3]. - The company has a debt-to-asset ratio of 13.3% and a price-to-earnings ratio of 33.59 [3]. Financial Performance - The company anticipates a revenue forecast adjustment for 2025-2027 to 16.97/20.06/22.49 billion yuan, reflecting a year-on-year growth of 43.51%/18.22%/12.11% [7]. - The expected net profit for the same period is revised to 2.21/2.65/2.99 billion yuan, with corresponding year-on-year growth rates of 40.42%/20.0%/12.91% [9]. Profitability and Cost Structure - The report notes that the shift in channel structure has impacted gross margins, with a higher proportion of low-margin sales through membership supermarkets and snack channels [6]. - Despite the increase in absolute expenses due to brand investments in online and traditional channels, the overall expense ratio is expected to decline [6].

证券研究报告：机械设备|深度报告 发布时间：2025-07-14 行业投资评级 强于大市|维持 | 行业基本情况 | | --- | | 收盘点位 | | 1674.53 | | --- | --- | --- | | 52 | 周最高 | 1803.12 | | 52 | 周最低 | 1122.98 | 行业相对指数表现（相对值） -9% -3% 3% 9% 15% 21% 27% 33% 39% 45% 2024-07 2024-09 2024-12 2025-02 2025-04 2025-07 机械设备 沪深300 资料来源：聚源，中邮证券研究所 研究所 分析师:刘卓 SAC 登记编号:S1340522110001 Email:liuzhuo@cnpsec.com 分析师:傅昌鑫 SAC 登记编号:S1340524070004 Email:fuchangxin@cnpsec.com 近期研究报告 《智元 G1、A2 等核心产品启动一定规 模量产》 - 2025.07.07 智元机器人控股上纬新材，中标中国移动人形机器 人代工订单 ⚫ 本周行情回顾 本周（2025.07.07-07.11）人形机器人指数 ...

发布时间：2025-07-14 大盘指数 7000 8000 9000 10000 11000 12000 2000 3000 4000 上证指数 深证成指 1000 2000 3000 5000 6000 7000 8000 中小100 创业板指 资料来源：聚源，中邮证券研究所 研究所 分析师:黄子崟 SAC 登记编号:S1340523090002 Email:huangziyin@cnpsec.com 近期研究报告 《关键节点将近，A 股或震荡消化涨幅》 - 2025.07.07 策略观点 红利研究（1）：为什么是银行？终点又在何处 ⚫ 投资要点 1.为什么红利股能持续上涨？ 一个反直觉的结论，投资回报率走低的低利率环境有利于红利估 值上移。红利股策略也可以视为一个类债策略，于是我们可以把红利 股股息的一部分视为债券的利息，另一部分是持有股票这一高风险高 波动资产相对持有债券所要求的补偿。即可将红利股的股息率写作： 红利股股息率=无风险利率+本金风险补偿+股债差异补偿 社会整体的投资回报率走低后出现流动性陷阱，红利股的高股息 对于深陷债权类资产荒的资金而言是一个不可多得的回报来源，信用 利差的极致收窄使得 ...

证券研究报告：固定收益报告 发布时间：2025-07-14 研究所 分析师:梁伟超 SAC 登记编号:S1340523070001 Email:liangweichao@cnpsec.com 分析师:崔超 SAC 登记编号:S1340523120001 Email:cuichao@cnpsec.com 近期研究报告 《【中邮固收】科创债规模和跨市场利 差怎么看？——科创债专题之三 20250711》 - 2025.07.11 生产：钢铁产业链下降，沥青、PTA、轮胎开工率升高 7 月 11 日当周，焦炉产能利用率下降 0.48 pct，高炉开工率下 降 0.31 pct，螺纹钢产量下降 4.42 万吨；石油沥青开工率升高 1.0 pct；化工 PX 开工率下降 0.74 pct，PTA 开工率升高 1.43 pct；汽车 全钢胎开工率升高 0.81 pct，半钢胎开工率升高 2.51 pct。 需求：商品房成交边际回落，BDI 触底反弹 7 月 6 日当周，商品房成交面积下降，存销比下降；土地成交面 积持续回升，住宅用地成交溢价率下降；电影票房较前一周增加 1.98 亿元；汽车厂家日均零售减少 5.57 万辆 ...